Dr Nathan Rout-Pitt

Grant funded researcher (B)

School of Medicine

College of Health

Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.


Lung fibrosis in cystic fibrosis (CF) remains poorly defined, with few studies exploring its development or underlying cellular mechanisms over the past 10–15 years. My research explores the premise that this process of fibrosis is hindering the effectiveness of clinically approved therapies (e.g. modulators) and those under development (e.g. gene therapy). At the University of Adelaide Cystic Fibrosis Airway Research Group, our goal is to cure CF airway disease through CFTR gene-addition therapy. Gene therapy efforts have often prioritized speed to clinic over understanding CF’s biological complexity, meaning that there are still no gene therapies on the market for CF. While CFTR modulator drugs like Trikafta have improved care for many, they are ineffective for about 30% of patients due to ineligible mutations, side effects, or limited benefit. My research goal is to ‘Cure CF through a deeper understanding of its biological complexity’, including assessing signalling pathways that drive fibrosis.The main focuses of my current research include:- Modeling CF lung disease in rats.- Identifying fibrosis-related pathways in CF.- Linking these fibrosis related pathways to CFTR trafficking.- Evaluating the Reversibility of fibrotic signaling pathways.

Honours projects currently available

Project 1

Title: Identifying altered pathways that lead to increased lung stiffness in CF rats models

Description: Our group has access to two CF rat models containing different mutations (A Phe508del mutation which results in misfolded version of the protein, and a KO mutation with a truncated non-functional protein). CF rat models typically do not develop overt lung disease like humans, however, our newer data suggests that there is evidence of more subtle alterations to the lungs of our CF rat models including lung stiffness; a sign of fibrotic tissue. We have also shown that the gene expression profiles of these two CF rat models are not only different to wildtype rats, but also each other. One of the more obvious changes is collagen type 1 production which is increased in Phe508del rats, but decreased in KO rats.

There are currently a number of sub-projects within this project looking at:

1) Further characterising changes in signalling pathways in these rats using RNAseq,

2) Understanding the effect of Phe508del mutant CFTR protein on signalling pathways,

3) Developing and characterising a rat fibrotic lung model, and

4) Determining whether current CFTR modulator therapies or potential lentiviral gene therapies can fully correct these altered signalling pathways.    

These projects will utilise a range of skills including RNAseq analysis, qPCR, Western blotting, cell culture, and immunohistochemistry. These projects may also involve mass spectrometry for lipid analysis and the use of a novel In Vivo Oxidative Status (IVOS) probe to measure oxidative stress levels in the CF rats. 

Co-supervisor(s): A. Prof Martin Donnelley, Dr Alexandra McCarron, A. Prof Erik Noschka (Project dependent)

Projects available for: Honours and Masters

Location: Women's and Children's Hospital

Research project start: Semester 1 or 2

 

 

Date Position Institution name
2022 - ongoing Postdoctoral researcher University of Adelaide
2021 - 2022 Postdoctoral researcher SA Pathology
2018 - 2020 Postdoctoral researcher University of Adelaide
2015 - 2018 Research Assistant University of Adelaide

Date Institution name Country Title
2011 - 2015 University of Adelaide Australia PhD
2010 - 2010 Flinders University Australia BSc (Honours)
2007 - 2009 Flinders Univerity Australia Bachelor of Science

Year Citation
2025 Rout-Pitt, N., Boog, B., McCarron, A., Reyne, N., Parsons, D., & Donnelley, M. (2025). Insights into epithelial-mesenchymal transition from cystic fibrosis rat models. Journal of Cystic Fibrosis, 24(1), 149-156.
DOI Scopus4 WoS4 Europe PMC4
2024 McCarron, A., Ling, K. -M., Montgomery, S. T., Martinovich, K. M., Cmielewski, P., Rout-Pitt, N., . . . Donnelley, M. (2024). Lentiviral vector gene therapy and CFTR modulators show comparable effectiveness in cystic fibrosis rat airway models. Gene Therapy, 31(11-12), 553-559.
DOI Scopus1 WoS1 Europe PMC1
2023 Shrestha, N., Rout-Pitt, N., McCarron, A., Jackson, C. A., Bulmer, A. C., McAinch, A. J., . . . Hryciw, D. H. (2023). Changes in Essential Fatty Acids and Ileal Genes Associated with Metabolizing Enzymes and Fatty Acid Transporters in Rodent Models of Cystic Fibrosis. International Journal of Molecular Sciences, 24(8), 7194-1-7194-10.
DOI Scopus3 WoS3 Europe PMC3
2023 Donnelley, M., Cmielewski, P., Knight, E., Carpentieri, C., McCarron, A., Rout-Pitt, N., . . . Farrow, N. (2023). Repeat or single-dose lentiviral vector administration to mouse lungs? It’s all about the timing. Gene Therapy, 30(9), 1-8.
DOI Scopus4 WoS4 Europe PMC5
2022 Donnelley, M., Cmielewski, P., Morgan, K., Delhove, J., Reyne, N., McCarron, A., . . . Parsons, D. (2022). Improved in-vivo airway gene transfer via magnetic-guidance, with protocol development informed by synchrotron imaging. Scientific Reports, 12(1), 9000-1-9000-14.
DOI Scopus2 WoS2 Europe PMC2
2022 Shrestha, N., McCarron, A., Rout-Pitt, N., Donnelley, M., Parsons, D. W., & Hryciw, D. H. (2022). Essential Fatty Acid Deficiency in Cystic Fibrosis Disease Progression: Role of Genotype and Sex. Nutrients, 14(21), 4666.
DOI Scopus8 WoS9 Europe PMC9
2021 Farrow, N. R., Cmielewski, P., Delhove, J., Rout-Pitt, N., Vaughan, L., Kuchel, T., . . . Parsons, D. (2021). Towards human translation of lentiviral airway gene delivery for cystic fibrosis: A one-month CFTR and reporter gene study in marmosets. Human Gene Therapy, 32(15-16), 806-816.
DOI Scopus10 WoS9 Europe PMC3
2021 Carpentieri, C. L., Farrow, N. R., Cmielewski, P., Rout-Pitt, N., Mc Carron, A., Knight, E., . . . Donnelley, M. (2021). The effects of conditioning and lentiviral vector pseudotype on short- and long-term airway reporter gene expression in mice.. Human Gene Therapy, 32(15-16), 817-827.
DOI Scopus4 WoS5 Europe PMC4
2021 Rout-Pitt, N., Donnelley, M., & Parsons, D. (2021). In vitro optimization of miniature bronchoscope lentiviral vector delivery for the small animal lung. Experimental Lung Research, 47(9), 417-425.
DOI Europe PMC1
2020 McCarron, A., Cmielewski, P., Reyne, N., McIntyre, C., Finnie, J., Craig, F., . . . Donnelley, M. (2020). Phenotypic characterization and comparison of Phe508del and cystic fibrosis transmembrane conductance regulator (CFTR) knockout rat models of cystic fibrosis generated by CRISPR/Cas9 gene editing. The American Journal of Pathology, 190(5), 977-993.
DOI Scopus37 WoS34 Europe PMC35
2018 Rout-Pitt, N., Farrow, N., Parsons, D., & Donnelley, M. (2018). Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology. Respiratory Research, 19(1), 136-1-136-10.
DOI Scopus242 WoS234 Europe PMC195
2018 McIntyre, C., Donnelley, M., Rout-Pitt, N., & Parsons, D. (2018). Lobe-specific gene vector delivery to rat lungs using a miniature bronchoscope. Human Gene Therapy Methods, 29(5), 228-235.
DOI Scopus17 WoS16 Europe PMC13
2018 Farrow, N., Donnelley, M., Cmielewski, P., Roscioli, E., Rout-Pitt, N., McIntyre, C., . . . Parsons, D. (2018). Role of basal cells in producing persistent lentivirus-mediated airway gene expression. Human Gene Therapy, 29(6), 653-662.
DOI Scopus16 WoS17 Europe PMC13
2018 Rout-Pitt, N. B., McCarron, A., McIntyre, C., Parsons, D., & Donnelley, M. (2018). Large-scale production of lentiviral vectors using multilayer cell factories. Journal of Biological Methods, 5(2), e90-1-e90-9.
DOI Europe PMC21
2018 Farrow, N., Cmielewski, P., Donnelley, M., Rout-Pitt, N., Moodley, Y., Bertoncello, I., & Parsons, D. (2018). Epithelial disruption: a new paradigm enabling human airway stem cell transplantation. Stem Cell Research and Therapy, 9(1), 153-1-153-8.
DOI Scopus22 WoS20 Europe PMC21
2015 Jackson, M., Derrick Roberts, A., Martin, E., Rout-Pitt, N., Gronthos, S., & Byers, S. (2015). Mucopolysaccharidosis enzyme production by bone marrow and dental pulp derived human mesenchymal stem cells. Molecular Genetics and Metabolism, 114(4), 584-593.
DOI Scopus10 WoS11 Europe PMC11
2012 Bowyer, J., Rout-Pitt, N., Bain, P., Stone, D., & Schuller, K. (2012). Dietary fish oil replacement with canola oil up-regulates glutathione peroxidase 1 gene expression in yellowtail kingfish (Seriola lalandi). Comparative Biochemistry and Physiology B- Biochemistry and Molecular Biology, 162(4), 100-106.
DOI Scopus18 WoS17 Europe PMC11

Year Citation
2015 Byers, S., Pout-Pitt, N., Linard, H., Ainslie, L. K., & Roberts, S. A. D. (2015). MPS GAG modulate mesenchymal stem cell differentiation. In MOLECULAR GENETICS AND METABOLISM Vol. 114 (pp. S27-S28). Orlando, FL: ACADEMIC PRESS INC ELSEVIER SCIENCE.
DOI

Year Citation
2023 Rout-Pitt, N., Mc Carron, A., Boog, B., Parsons, D., & Donnelley, M. (2023). A twist in the cystic fibrosis story—TGF-β1 treatment affects epithelialmesenchymal transition differentially in two cystic fibrosis rat airway cell models. Poster session presented at the meeting of North American Cystic Fibrosis Conference.
2020 Rout-Pitt, N., Delhove, J., Farrow, N., Donnelley, M., & Parsons, D. (2020). Development of an Epithelial Mesenchymal Transition Tracing Vector. Poster session presented at the meeting of MOLECULAR THERAPY. ELECTR NETWORK: CELL PRESS.
2020 Carpentieri, C., Farrow, N., Cmielewski, P., Delhove, J., Rout-Pitt, N., Parsons, D., & Donnelley, M. (2020). Frequency and Timing of Lentiviral Vector Repeat Dose Delivery Does Not Significantly Alter Long-Term Transgene Expression Levels in Mouse Lungs. Poster session presented at the meeting of MOLECULAR THERAPY. ELECTR NETWORK: CELL PRESS.
2019 Rout-Pitt, N., Donnelley, M., & Parsons, D. (2019). OPTIMISATION OF BRONCHOSCOPIC LENTIVIRAL VECTOR DELIVERY FOR DIRECT LOBE TARGETING IN RAT LUNGS. Poster session presented at the meeting of RESPIROLOGY. WILEY.
2018 Byers, S., Rout-Pitt, N., Linard, H., Vaidyanathan, S., & Derrick-Roberts, A. L. K. (2018). MESENCHYMAL STEM CELL DIFFERENTIATION IS MODULATED BY COMPLEX SUGARS IN MPS DISEASE. Poster session presented at the meeting of JOURNAL OF GENE MEDICINE. Univ Technol Sydney, Sydney, AUSTRALIA: WILEY.
2018 McIntyre, C., Rout-Pitt, N., Donnelley, M., & Parsons, D. (2018). LOBE SPECIFIC TARGETING OF LENTIVIRAL VECTOR GENE TRANSFER TO THE LUNGS OF ADULT RATS. Poster session presented at the meeting of PEDIATRIC PULMONOLOGY. WILEY.
2018 McIntyre, C., Cmielewski, P., Craig, F., Rout-Pitt, N., Parsons, D., & Donnelley, M. (2018). CF-RELATED PATHOLOGIES ARE MORE SEVERE IN KNOCKOUT RATS COMPARED TO PHE508DEL RATS. Poster session presented at the meeting of PEDIATRIC PULMONOLOGY. WILEY.
2018 Carpentieri, C., Farrow, N., Cmielewski, P., McIntyre, C., McCarron, A., Rout-Pitt, N., . . . Donnelley, M. (2018). Airway Gene-Addition Therapy for Cystic Fibrosis: the VSV-G Pseudotype Produces Higher Transduction Levels Than HA. Poster session presented at the meeting of MOLECULAR THERAPY. Chicago, IL: CELL PRESS.
2018 Farrow, N., Cmielewski, P., Donnelley, M., Rout-Pitt, N., Bertoncello, I., & Parsons, D. (2018). Epithelial Disruption Enables Human Airway Stem Cell Transplantation in Mouse Nasal Airways. Poster session presented at the meeting of MOLECULAR THERAPY. Chicago, IL: CELL PRESS.
2018 Carpentieri, C., Farrow, N., Mcintyre, C., Cmielewski, P., Rout-Pitt, N., Parsons, D., & Donnelley, M. (2018). COMPARATIVE EFFICIENCY OF HA AND VSV-G PSEUDOTYPED LENTIVIRAL VECTORS FOR CYSTIC FIBROSIS AIRWAY GENE THERAPY. Poster session presented at the meeting of RESPIROLOGY. WILEY.
2017 Farrow, N., Donnelley, M., McIntyre, C., Rout-Pitt, N., & Parsons, D. (2017). Developing high efficiency gene transfer techniques using human air liquid interface cultures. Poster session presented at the meeting of TSANZ Poster presentations, as published in Respirology. Canberra: Wiley.
2017 McCarron, A., Rout-Pitt, N., McIntyre, C., Donnelley, M., & Parsons, D. W. D. (2017). Lentivirus Production in Stirred-Tank and Packed-Bed Basket Bioreactor Systems: A Comparison. Poster session presented at the meeting of MOLECULAR THERAPY. Washington, DC: CELL PRESS.
2017 Farrow, N., Donnelley, M., Rout-Pitt, N., McIntyre, C., Bertoncello, I., & Parsons, D. W. D. (2017). High Efficiency <i>In Vitro</i> Transduction of Human Airway Basal Cells. Poster session presented at the meeting of MOLECULAR THERAPY. Washington, DC: CELL PRESS.
2017 Carpentieri, C. L., Farrow, N., McIntyre, C., McCarron, A., Rout-Pitt, N., Parsons, D., & Donnelley, M. (2017). COMPARATIVE EFFICIENCY OF HA AND VSV-G PSEUDOTYPED LENTIVIRAL VECTORS DEVELOPED FOR TREATING CYSTIC FIBROSIS LUNG DISEASE. Poster session presented at the meeting of PEDIATRIC PULMONOLOGY. WILEY.

Year Citation
2025 Rout-Pitt, N., Barnes, S., Reyne, N., McCarron, A., Donnelley, M., Kostecki, R., & Noschka, E. (2025). Evaluating an In Vivo Oxidative Stress sensor in cystic fibrosis rat epithelial tissues.
DOI

2025 N. Rout-Pitt, Robinson Research Institute Step Funding, "Characterising basal epithelial stem cell subpopulations in cystic fibrosis airways: Investigating the inherent risk of fibrosis", $40,000

2025 N. Rout-Pitt, A, McCarron, M, Donnelley, Cystic Fibrosis Australia Conquer Cystic Fibrosis Gene Therapies Innovation grant, "Improving CFTR gene therapy by ensuring airway cells exist in an epithelial state", $80,000 

2024 N. Rout-Pitt, Robinson Research Institute Step Funding, "Assessing how lipid metabolism changes in Cystic Fibrosis epithelial cells during Epithelial Mesenchymal Transition", $15,000

2024 N. Rout-Pitt, A. McCarron, D. Parsons, M. Donnelley, Fall Path to a cure (PTAC) Pilot and Feasibility Award Program of the Cystic Fibrosis Foundation (CFF): 'Unravelling the Role of Epithelial-Mesenchymal Transition (EMT) in Cystic Fibrosis Lung Disease: Insights, Challenges, and Therapeutic Prospects', $175,000

2019 N. Rout-Pitt, N. Farrow, J. Delhove, D. Parsons, M. Donnelley, WCH Foundation Grant: “Cell plasticity of the airways: Understanding the stem cell niche to optimise gene therapy and stem cell targeting”, $75,000

2018 N. Rout-Pitt, Cure 4 Cystic Fibrosis Foundation Grant: "Lentiviral vector production facility management", $41,828

2017 M. Donnelley, C. McIntyre, N. Rout-Pitt, A. McCarron, D. Parsons, Channel 7 Children's Research Foundation Grant: “Improving the efficiency of cystic fibrosis airway gene therapy”, $74,213

 

I am passionate about science and have over ten years research experience as a molecular biologist in bone and respiratory diseases in multi-disciplinary teams delivering high quality research.

I have supervised 3rd year placement, honours, masters and PhD students. My first student in the Masters of Biotechnology program within the School of Biological Sciences provided with a glowing thank you in her thesis.

'...I would like to thank my other supervisor, Dr Nathan Rout-Pitt. Thank you for your careful guidance to my every experiment and giving me the most detailed opinions in the process of my writing. I think he is the most responsible and patient supervisor I have seen in Australia in the past two years. Even in my 18 years of school, I haven't met such a good supervisor as him'

Date Role Research Topic Program Degree Type Student Load Student Name
2024 Co-Supervisor Developing an effective airway stem cell therapy for the treatment of Cystic Fibrosis lung disease Doctor of Philosophy Doctorate Full Time Ms Stuti Saini
2023 Co-Supervisor Understanding and improving gene vector targeting with lentiviral magnetic nanoparticles Doctor of Philosophy under a Jointly-awarded Degree Agreement with Doctorate Part Time Ms Madison Michelle Davis

Date Role Committee Institution Country
2024 - ongoing Member IBC committee University of Adelaide Australia
2017 - 2020 Representative EMCR council Robinson Research Institute Australia

Date Role Membership Country
2022 - ongoing Member The EMT International Association Australia
2020 - 2021 Member American Society of Gene and Cell Therapy United States
2019 - 2020 Member Australian and New Zealand Society of Respiratory Science Australia

Connect With Me

External Profiles

Other Links